Abaxis, Inc. (NASDAQ:ABAX) Ratings Summary on Jun 29, 2018

June 29, 2018 - By Carey Conley

Abaxis, Inc. (NASDAQ:ABAX) Corporate Logo
During Q1 2018 the big money sentiment increased to 1.48. That’s change of 0.21, from 2017Q4’s 1.27. 11 investors sold all, 45 reduced holdings as Abaxis, Inc. ratio improved. 46 grew stakes while 37 funds acquired stakes. Funds hold 20.94 million shares thus 3.32% less from 2017Q4’s 21.66 million shares.
Spark Invest Mgmt Ltd Limited Liability Company has invested 0.05% in Abaxis, Inc. (NASDAQ:ABAX). Pinebridge Limited Partnership, New York-based fund reported 24,584 shs. Glenmede Tru Com Na accumulated 88 shs. Atria Investments Lc has invested 0.02% in Abaxis, Inc. (NASDAQ:ABAX). Citigroup holds 0% or 5,268 shs in its capital. Moreover, Primecap Mgmt Ca has 0.12% invested in Abaxis, Inc. (NASDAQ:ABAX) for 2.22 million shs. Goldman Sachs Grp Inc holds 95,757 shs or 0% of its capital. Renaissance Techs Limited Com holds 0.01% of its capital in Abaxis, Inc. (NASDAQ:ABAX) for 135,400 shs. 6,296 were accumulated by Mason Street Advsr Ltd Co. Verition Fund Ltd stated it has 3,663 shs or 0.02% of all its holdings. The New York-based Morgan Stanley has invested 0% in Abaxis, Inc. (NASDAQ:ABAX). Citadel Limited Liability, Illinois-based fund reported 4,654 shs. Jpmorgan Chase And stated it has 0% of its capital in Abaxis, Inc. (NASDAQ:ABAX). Tci Wealth Advsrs holds 0% of its capital in Abaxis, Inc. (NASDAQ:ABAX) for 26 shs. Parkside Natl Bank Tru invested in 19 shs or 0% of the stock.

Abaxis, Inc. registered $5.31 million net activity with 0 insider purchases and 13 selling transactions since January 30, 2018. On Tuesday, March 6 Henkel Achim sold $304,953 worth of Abaxis, Inc. (NASDAQ:ABAX). CASEY MICHAEL D had sold 5,000 shs worth $355,327. $689,851 worth of Abaxis, Inc. (NASDAQ:ABAX) was sold by WOOD DONALD PETER on Tuesday, March 6. SINGH PRITHIPAL sold $140,500 worth of Abaxis, Inc. (NASDAQ:ABAX) on Tuesday, March 6. On Wednesday, January 31 TOCKMAN CRAIG had sold 1,650 shs worth $122,652. EVENHUIS HENK had sold 4,500 shs worth $333,460.

Abaxis, Inc. (NASDAQ:ABAX) Ratings Coverage

In total 8 analysts cover Abaxis (NASDAQ:ABAX). “Buy” rating has 1, “Sell” are 1, while 6 are “Hold”. (NASDAQ:ABAX) has 13% bullish analysts. 11 are the (NASDAQ:ABAX)’s ratings reports on Jun 29, 2018 according to StockzIntelligence Inc. On Wednesday, May 16 the company was upgraded by Credit Suisse. On Thursday, February 8 Bank of America maintained Abaxis, Inc. (NASDAQ:ABAX) rating. Bank of America has “Underperform” rating and $48 target. On Tuesday, January 16 the firm earned “Hold” rating by Canaccord Genuity. On Friday, April 27 the rating was maintained by Stifel Nicolaus with “Hold”. On Wednesday, May 16 the rating was downgraded by Sidoti to “Neutral”. On Tuesday, January 9 the firm has “Hold” rating given by Raymond James. In Tuesday, January 9 report Northcoast maintained it with “Buy” rating and $72.0 target. On Monday, January 29 the stock has “Buy” rating by Northcoast. On Thursday, January 25 Stifel Nicolaus maintained the shares of ABAX in report with “Hold” rating. On Monday, January 29 the stock of Abaxis, Inc. (NASDAQ:ABAX) has “Hold” rating given by Canaccord Genuity. Listed here are Abaxis, Inc. (NASDAQ:ABAX) PTs and latest ratings.

16/05/2018 Broker: Credit Suisse Rating: Hold Upgrade
16/05/2018 Broker: Sidoti Old Rating: Buy New Rating: Neutral Downgrade
27/04/2018 Broker: Stifel Nicolaus Old Rating: Hold New Rating: Hold Old Target: $57 New Target: $62 Maintain
08/02/2018 Broker: Bank of America Old Rating: Underperform New Rating: Underperform Old Target: $46 New Target: $48 Maintain
29/01/2018 Broker: Northcoast Rating: Buy New Target: $90.0 Maintain
29/01/2018 Broker: Canaccord Genuity Rating: Hold New Target: $65.0 Maintain
26/01/2018 Broker: Stephens Rating: Hold New Target: $60.0 Maintain
25/01/2018 Broker: Stifel Nicolaus Rating: Hold New Target: $57.0 Maintain
16/01/2018 Broker: Canaccord Genuity Rating: Hold New Target: $55.0 Maintain
09/01/2018 Broker: Northcoast Rating: Buy New Target: $72.0 Maintain

ABAX touched $83.15 during the last trading session after $0.05 change.Abaxis, Inc. has volume of 14,333 shares. Since June 29, 2017 ABAX has risen 69.53% and is uptrending. The stock outperformed the S&P 500 by 56.96%.

Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care settings to provide rapid blood constituent measurements for clinicians worldwide.The firm is worth $1.90 billion. It operates in two divisions, Medical Market and Veterinary Market.The P/E ratio is 71.07. The firm offers Piccolo chemistry analyzers with rapid blood constituent measurements for use in human patient care; and Piccolo profiles that are single-use medical reagents.

Another two news for Abaxis, Inc. (NASDAQ:ABAX) were briefly released by: Prnewswire.com on June 05, 2018 with title “SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Abaxis, Inc. – ABAX”. The other Investorplace.com‘s article was titled “7 Stocks to Buy That Aren’t in the Dow But Should Be” and released on June 28, 2018.

Abaxis, Inc. (NASDAQ:ABAX) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.